Europe — EMA
Ocaliva (Obeticholic Acid)
Obeticholic acid, the active ingredient in Ocaliva, is a farnesoid X receptor (FXR) agonist presented as a oral tablet for oral use. It is indicated for the treatment of primary biliary cholangitis in adults.
Request sourcing
What is Obeticholic Acid?
Obeticholic acid, the active ingredient in Ocaliva, is a farnesoid X receptor (FXR) agonist presented as a oral tablet for oral use. It is indicated for the treatment of primary biliary cholangitis in adults.
GNH USA supplies Ocaliva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.
What is Obeticholic Acid used for?
Ocaliva is a farnesoid X receptor agonist used in cholestatic liver disease management: - Primary biliary cholangitis: improves liver biochemistry and slows disease progression. - Primary sclerosing cholitis: investigated but not approved. - Non‑alcoholic fatty liver disease: studied in clinical trials.
What are the side effects of Obeticholic Acid?
Obeticholic
